Lempicki R A, Kovacs J A, Baseler M W, Adelsberger J W, Dewar R L, Natarajan V, Bosche M C, Metcalf J A, Stevens R A, Lambert L A, Alvord W G, Polis M A, Davey R T, Dimitrov D S, Lane H C
Science Applications International Corporation-Frederick, Clinical Services Program, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702, USA.
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13778-83. doi: 10.1073/pnas.250472097.
To evaluate the effects of HIV infection on T cell turnover, we examined levels of DNA synthesis in lymph node and peripheral blood mononuclear cell subsets by using ex vivo labeling with BrdUrd. Compared with healthy controls (n = 67), HIV-infected patients (n = 57) had significant increases in the number and fraction of dividing CD4(+) and CD8(+) T cells. Higher percentages of dividing CD4(+) and CD8(+) T cells were noted in patients with the higher viral burdens. No direct correlation was noted between rates of T cell turnover and CD4(+) T cell counts. Marked reductions in CD4(+) and CD8(+) T cell proliferation were seen in 11/11 patients 1-12 weeks after initiation of highly active antiretroviral therapy (HAART). These reductions persisted for the length of the study (16-72 weeks). Decreases in naive T cell proliferation correlated with increases in the levels of T cell receptor rearrangement excision circles. Division of CD4(+) and CD8(+) T cells increased dramatically in association with rapid increases in HIV-1 viral loads in 9/9 patients 5 weeks after termination of HAART and declined to pre-HAART-termination levels 8 weeks after reinitiation of therapy. These data are consistent with the hypothesis that HIV-1 infection induces a viral burden-related, global activation of the immune system, leading to increases in lymphocyte proliferation.
为评估HIV感染对T细胞更新的影响,我们通过用BrdUrd进行体外标记,检测了淋巴结和外周血单个核细胞亚群中的DNA合成水平。与健康对照者(n = 67)相比,HIV感染患者(n = 57)中正在分裂的CD4(+)和CD8(+) T细胞数量及比例显著增加。病毒载量较高的患者中,正在分裂的CD4(+)和CD8(+) T细胞百分比更高。未发现T细胞更新率与CD4(+) T细胞计数之间存在直接相关性。在开始高效抗逆转录病毒治疗(HAART)后1至12周,11/11例患者的CD4(+)和CD8(+) T细胞增殖明显减少。这些减少在研究期间(16至72周)持续存在。初始T细胞增殖的减少与T细胞受体重排切除环水平的增加相关。在9/9例患者停止HAART 5周后,随着HIV-1病毒载量的迅速增加,CD4(+)和CD8(+) T细胞的分裂显著增加,并在重新开始治疗8周后降至HAART终止前水平。这些数据与以下假设一致,即HIV-1感染诱导与病毒载量相关的免疫系统整体激活,导致淋巴细胞增殖增加。